ABI Grabs Bigger Piece of Mass Spec Market, While Waters Sales Suffer | GenomeWeb

Both Waters and Applied Biosystems were bombarded with questions from analysts regarding their mass spectrometers when they reported their quarterly earnings last month. However, the reasons for this intense scrutiny differed: While ABI reported an “extraordinary increase in mass spectrometry revenue of more than 50 percent over the prior year period,” Waters stated that its mass spec business for the quarter was down by a percentage “in the double digits,” compared to last year’s quarter.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.

A cancer researcher retracts 19 articles from one journal for image manipulation, according to Retraction Watch.

Precision medicine has to consider context in addition to genetic mutations in cancer treatment, Medscape reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.